$OMDA

Gracey Craig sold $85K of OMDA

Gracey Craig (Chief Accounting Officer) sold 4,167 shares of Omada Health, Inc. (OMDA) at an average of $20.50 ($20.00–$21.00) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 30, 2026, 11:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 11:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure updates OMDA’s insider trading record but does not include any new company performance, guidance, or strategic information.

02

Market read

Traders may log the insider sale for sentiment/positioning, but it is unlikely to drive a fundamental repricing.

03

What to watch

The sale size is modest and the plan is pre-arranged; without additional context (e.g., other insiders selling/buying), the signal is weak.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-30 after-hours; reflects trades dated 2026-06-26 to 2026-06-29.

Background

The filing is an SEC Form 4 insider transaction for Omada Health, reported by Chief Accounting Officer Gracey Craig.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health insider Gracey Craig (Chief Accounting Officer) sold about $85.4K of OMDA stock via an open-market sale under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

Form 4 shows a small, pre-arranged 10b5-1 sale (weighted avg ~$20.50) by an accounting officer, with no accompanying operational or guidance change.

Market effects

No clear read-across to the healthcare/telehealth sector from a single small 10b5-1 insider sale.

No material regional impact indicated.

No global implications indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal views on near-term valuation, so traders may watch for follow-on insider activity.

Key entities

  • Omada Health, Inc.

    Issuer of the Form 4 insider sale disclosed on 2026-06-30.

  • Gracey Craig

    Chief Accounting Officer who sold 4,167 shares under a pre-arranged 10b5-1 plan.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom